Guggenheim Capital LLC Johnson & Johnson Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Guggenheim Capital LLC holds 309,860 shares of JNJ stock, worth $45 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

309,860

Previous 285,275 8.62%

Holding current value

$45 Million

Previous $41.7 Million 20.43%

% of portfolio

0.36%

Previous 0.3%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$145.48 - $167.38 $3.58 Million - $4.12 Million	24,585 Added 8.62%	309,860 $50.2 Million
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $201,843 - $220,576	-1,398 Reduced 0.49%	285,275 $41.7 Million
Q1 2024 May 14, 2024	BUY	$155.22 - $162.74 $4.2 Million - $4.4 Million	27,049 Added 10.42%	286,673 $45.3 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $1.15 Million - $1.26 Million	7,905 Added 3.14%	259,624 $40.7 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $10.9 Million - $12.2 Million	-70,025 Reduced 21.76%	251,719 $39.2 Million
Q2 2023 Aug 11, 2023	SELL	$154.35 - $166.11 $4.06 Million - $4.37 Million	-26,293 Reduced 7.55%	321,744 $53.3 Million
Q1 2023 May 10, 2023	SELL	$151.05 - $180.26 $2.96 Million - $3.53 Million	-19,601 Reduced 5.33%	348,037 $53.9 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $2.9 Million - $3.26 Million	-18,127 Reduced 4.7%	367,638 $64.9 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $394,290 - $438,746	-2,444 Reduced 0.63%	385,765 $63 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $13.3 Million - $14.7 Million	-78,791 Reduced 16.87%	388,209 $68.9 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $2.45 Million - $2.79 Million	-15,515 Reduced 3.22%	467,000 $82.8 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $5.69 Million - $6.31 Million	36,488 Added 8.18%	482,515 $82.5 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $4.54 Million - $5.04 Million	28,098 Added 6.72%	446,027 $72 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $1.42 Million - $1.52 Million	-8,877 Reduced 2.08%	417,929 $68.8 Million
Q1 2021 May 13, 2021	SELL	$153.07 - $170.48 $5.96 Million - $6.64 Million	-38,961 Reduced 8.36%	426,806 $70.1 Million
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $1.63 Million - $1.87 Million	11,884 Added 2.62%	465,767 $73.3 Million
Q3 2020 Nov 13, 2020	SELL	$140.38 - $153.83 $2.08 Million - $2.28 Million	-14,844 Reduced 3.17%	453,883 $67.6 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $7.31 Million - $8.82 Million	56,719 Added 13.77%	468,727 $65.9 Million
Q1 2020 Jun 02, 2020	SELL	$111.14 - $153.99 $1.28 Million - $1.78 Million	-11,556 Reduced 2.73%	412,008 $54 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $2.02 Million - $2.32 Million	-15,848 Reduced 3.61%	423,564 $61.8 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $2.75 Million - $3.07 Million	-21,623 Reduced 4.69%	439,412 $56.9 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $487,091 - $535,707	-3,714 Reduced 0.8%	461,035 $64.2 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $3.99 Million - $4.43 Million	31,716 Added 7.32%	464,749 $65 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $6.43 Million - $7.74 Million	-52,332 Reduced 10.78%	433,033 $55.9 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $1.34 Million - $1.57 Million	-10,997 Reduced 2.22%	485,365 $67.1 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $67.1 Million - $74.1 Million	-562,027 Reduced 53.1%	496,362 $60.2 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $3.82 Million - $4.53 Million	-30,568 Reduced 2.81%	1,058,389 $136 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $8.57 Million - $9.38 Million	65,278 Added 6.38%	1,088,957 $152 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $133 Million - $139 Million	1,023,679	1,023,679 $133 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $380B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Johnson & Johnson Transaction History